ESSILORLUXOTTICA (1EL.MI) Fundamental Analysis & Valuation

BIT:1EL • FR0000121667

207.6 EUR
-5 (-2.35%)
Last: Mar 9, 2026, 07:00 PM

This 1EL.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1EL. 1EL was compared to 65 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of 1EL while its profitability can be described as average. While showing a medium growth rate, 1EL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. 1EL.MI Profitability Analysis

1.1 Basic Checks

  • 1EL had positive earnings in the past year.
  • 1EL had a positive operating cash flow in the past year.
  • 1EL had positive earnings in each of the past 5 years.
  • 1EL had a positive operating cash flow in each of the past 5 years.
1EL.MI Yearly Net Income VS EBIT VS OCF VS FCF1EL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

1.2 Ratios

  • With a Return On Assets value of 3.62%, 1EL perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • 1EL has a Return On Equity of 5.95%. This is comparable to the rest of the industry: 1EL outperforms 46.15% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.96%, 1EL is in line with its industry, outperforming 44.62% of the companies in the same industry.
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROIC 4.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1EL.MI Yearly ROA, ROE, ROIC1EL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1EL has a better Profit Margin (8.13%) than 61.54% of its industry peers.
  • 1EL's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 11.85%, 1EL is in line with its industry, outperforming 55.38% of the companies in the same industry.
  • 1EL's Operating Margin has improved in the last couple of years.
  • 1EL has a Gross Margin (59.69%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of 1EL has remained more or less at the same level.
Industry RankSector Rank
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
1EL.MI Yearly Profit, Operating, Gross Margins1EL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. 1EL.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1EL is destroying value.
  • There is no outstanding debt for 1EL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1EL.MI Yearly Shares Outstanding1EL.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1EL.MI Yearly Total Debt VS Total Assets1EL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • 1EL has an Altman-Z score of 2.98. This is not the best score and indicates that 1EL is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.98, 1EL perfoms like the industry average, outperforming 58.46% of the companies in the same industry.
  • The Debt to FCF ratio of 1EL is 3.82, which is a good value as it means it would take 1EL, 3.82 years of fcf income to pay off all of its debts.
  • 1EL's Debt to FCF ratio of 3.82 is fine compared to the rest of the industry. 1EL outperforms 63.08% of its industry peers.
  • 1EL has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • 1EL's Debt to Equity ratio of 0.24 is fine compared to the rest of the industry. 1EL outperforms 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Altman-Z 2.98
ROIC/WACC0.63
WACC7.89%
1EL.MI Yearly LT Debt VS Equity VS FCF1EL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.99 indicates that 1EL may have some problems paying its short term obligations.
  • 1EL has a worse Current ratio (0.99) than 78.46% of its industry peers.
  • A Quick Ratio of 0.70 indicates that 1EL may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.70, 1EL is not doing good in the industry: 73.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.7
1EL.MI Yearly Current Assets VS Current Liabilites1EL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. 1EL.MI Growth Analysis

3.1 Past

  • 1EL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.90%.
  • 1EL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.65% yearly.
  • 1EL shows a small growth in Revenue. In the last year, the Revenue has grown by 7.48%.
  • 1EL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.58% yearly.
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.89% on average over the next years. This is quite good.
  • 1EL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.09% yearly.
EPS Next Y17.32%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EPS Next 5Y13.89%
Revenue Next Year11.54%
Revenue Next 2Y11.17%
Revenue Next 3Y10.73%
Revenue Next 5Y8.09%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1EL.MI Yearly Revenue VS Estimates1EL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
1EL.MI Yearly EPS VS Estimates1EL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. 1EL.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1EL is valuated quite expensively with a Price/Earnings ratio of 30.31.
  • 1EL's Price/Earnings is on the same level as the industry average.
  • 1EL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.45, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.83 indicates a quite expensive valuation of 1EL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1EL is on the same level as its industry peers.
  • 1EL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.65.
Industry RankSector Rank
PE 30.31
Fwd PE 25.83
1EL.MI Price Earnings VS Forward Price Earnings1EL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 1EL's Enterprise Value to EBITDA is on the same level as the industry average.
  • 1EL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1EL is cheaper than 63.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.54
EV/EBITDA 16.5
1EL.MI Per share data1EL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • 1EL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1EL's earnings are expected to grow with 13.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.75
PEG (5Y)0.99
EPS Next 2Y16.06%
EPS Next 3Y13.67%

6

5. 1EL.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.67%, 1EL has a reasonable but not impressive dividend return.
  • The stock price of 1EL dropped by -27.16% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.01, 1EL pays a bit more dividend than its industry peers.
  • 1EL's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • The dividend of 1EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1EL pays out 23.63% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of 1EL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.63%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
1EL.MI Yearly Income VS Free CF VS Dividend1EL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
1EL.MI Dividend Payout.1EL.MI Dividend Payout, showing the Payout Ratio.1EL.MI Dividend Payout.PayoutRetained Earnings

1EL.MI Fundamentals: All Metrics, Ratios and Statistics

ESSILORLUXOTTICA

BIT:1EL (3/9/2026, 7:00:00 PM)

207.6

-5 (-2.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)04-22
Inst Owners28.97%
Inst Owner ChangeN/A
Ins Owners32.07%
Ins Owner ChangeN/A
Market Cap96.18B
Revenue(TTM)28.49B
Net Income(TTM)2.31B
Analysts85.16
Price Target330.67 (59.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP23.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.91%
PT rev (3m)-0.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.75%
Revenue NY rev (3m)4.08%
Valuation
Industry RankSector Rank
PE 30.31
Fwd PE 25.83
P/S 3.38
P/FCF 25.54
P/OCF 18.18
P/B 2.47
P/tB N/A
EV/EBITDA 16.5
EPS(TTM)6.85
EY3.3%
EPS(NY)8.04
Fwd EY3.87%
FCF(TTM)8.13
FCFY3.92%
OCF(TTM)11.42
OCFY5.5%
SpS61.5
BVpS83.94
TBVpS-4.05
PEG (NY)1.75
PEG (5Y)0.99
Graham Number113.74
Profitability
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROCE 6.52%
ROIC 4.96%
ROICexc 5.33%
ROICexgc 34.55%
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
FCFM 13.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Debt/EBITDA 1.46
Cap/Depr 48.99%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 81.55%
Profit Quality 162.68%
Current Ratio 0.99
Quick Ratio 0.7
Altman-Z 2.98
F-Score7
WACC7.89%
ROIC/WACC0.63
Cap/Depr(3y)49.88%
Cap/Depr(5y)48.88%
Cap/Sales(3y)5.71%
Cap/Sales(5y)5.75%
Profit Quality(3y)150.08%
Profit Quality(5y)168.44%
High Growth Momentum
Growth
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
EPS Next Y17.32%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EPS Next 5Y13.89%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%
Revenue Next Year11.54%
Revenue Next 2Y11.17%
Revenue Next 3Y10.73%
Revenue Next 5Y8.09%
EBIT growth 1Y-2.12%
EBIT growth 3Y2.98%
EBIT growth 5Y50.07%
EBIT Next Year73.26%
EBIT Next 3Y27.8%
EBIT Next 5Y18.52%
FCF growth 1Y12.35%
FCF growth 3Y5.46%
FCF growth 5Y10.35%
OCF growth 1Y8.56%
OCF growth 3Y3.42%
OCF growth 5Y12.38%

ESSILORLUXOTTICA / 1EL.MI FAQ

What is the fundamental rating for 1EL stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1EL.MI.


Can you provide the valuation status for ESSILORLUXOTTICA?

ChartMill assigns a valuation rating of 2 / 10 to ESSILORLUXOTTICA (1EL.MI). This can be considered as Overvalued.


What is the profitability of 1EL stock?

ESSILORLUXOTTICA (1EL.MI) has a profitability rating of 5 / 10.


What is the financial health of ESSILORLUXOTTICA (1EL.MI) stock?

The financial health rating of ESSILORLUXOTTICA (1EL.MI) is 4 / 10.


Can you provide the expected EPS growth for 1EL stock?

The Earnings per Share (EPS) of ESSILORLUXOTTICA (1EL.MI) is expected to grow by 17.32% in the next year.